AAV ‐mediated expression of galactose‐1‐phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AAV
‐mediated expression of galactose‐1‐phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts
Authors
Keywords
-
Journal
JOURNAL OF INHERITED METABOLIC DISEASE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-17
DOI
10.1002/jimd.12468
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluorinated Galactoses Inhibit Galactose-1-Phosphate Uridyltransferase and Metabolically Induce Galactosemia-like Phenotypes in HEK-293 Cells
- (2020) Verena Janes et al. Cells
- A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT ‐null rat pups
- (2020) Shauna A. Rasmussen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia
- (2019) Bijina Balakrishnan et al. MOLECULAR THERAPY
- Gene Therapy in Retinal Dystrophies
- (2019) Ziccardi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A galactose‐1‐phosphate uridylyltransferase‐null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue‐specific and longitudinal differences in galactose metabolism
- (2019) Shauna A. Rasmussen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Hereditary galactosemia
- (2018) Didem Demirbas et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation
- (2018) Megan L Brophy et al. CIRCULATION RESEARCH
- Classical Galactosemia: Insight into Molecular Pathomechanisms by Differential Membrane Proteomics of Fibroblasts under Galactose Stress
- (2017) Simon Staubach et al. JOURNAL OF PROTEOME RESEARCH
- Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts
- (2016) Bijina Balakrishnan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase
- (2016) Thomas J. McCorvie et al. HUMAN MOLECULAR GENETICS
- Downregulation of Insulin-Like Growth Factor-1 via Nitric Oxide Production in a Hypergalactosemic Model of Neonate Skin Fibroblast Cultures
- (2016) Gursev S. Dhaunsi et al. Neonatology
- Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development
- (2015) Baojun Chang et al. Nature Communications
- Physiological ER Stress Mediates the Differentiation of Fibroblasts
- (2015) Shinsuke Matsuzaki et al. PLoS One
- Novel Markers to Delineate Murine M1 and M2 Macrophages
- (2015) Kyle A. Jablonski et al. PLoS One
- Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model
- (2014) Manshu Tang et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Transforming Growth Factor-β Signaling Participates in the Maintenance of the Primordial Follicle Pool in the Mouse Ovary
- (2014) Zheng-Pin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic defects of ovarian TGF-β-like factors and premature ovarian failure
- (2014) L. Persani et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia
- (2013) Thomas J. McCorvie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
- (2013) Haoyi Wang et al. CELL
- The unfolded protein response has a protective role in yeast models of classic galactosemia
- (2013) E. A. De-Souza et al. Disease Models & Mechanisms
- Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia
- (2013) Shu-Jen Chen et al. Human Gene Therapy Clinical Development
- TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor
- (2012) Young-Woong Kim et al. BIOCHEMICAL JOURNAL
- Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling
- (2012) Satish Pasula et al. JOURNAL OF CLINICAL INVESTIGATION
- N- and O-linked glycosylation of total plasma glycoproteins in galactosemia
- (2012) Ying Liu et al. MOLECULAR GENETICS AND METABOLISM
- Regulation of the ovarian reserve by members of the transforming growth factor beta family
- (2012) Stephanie A. Pangas MOLECULAR REPRODUCTION AND DEVELOPMENT
- Response of Fibroblasts to Transforming Growth Factor-β1 on Two-Dimensional and in Three-Dimensional Hyaluronan Hydrogels
- (2012) Xia Chen et al. TISSUE ENGINEERING PART A
- Structural and molecular biology of type I galactosemia: Disease-associated mutations
- (2011) Thomas J. McCorvie et al. IUBMB LIFE
- Galactosemia, a Single Gene Disorder With Epigenetic Consequences
- (2010) David J Coman et al. PEDIATRIC RESEARCH
- Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders
- (2009) Miao Wang et al. ANTIOXIDANTS & REDOX SIGNALING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started